BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38102708)

  • 21. A role for matrix remodelling proteins in invasive and malignant meningiomas.
    Jalali S; Singh S; Agnihotri S; Wataya T; Salehi F; Alkins R; Burrell K; Navab R; Croul S; Aldape K; Zadeh G
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e16-28. PubMed ID: 24989599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells.
    Wang X; Xu J; Wang H; Wu L; Yuan W; Du J; Cai S
    Biochem Biophys Res Commun; 2015 Jan; 456(1):320-6. PubMed ID: 25434997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral Meningioma: A Case Report and Review of the Literature.
    Bukovac A; Panić H; Mrgan T; Šlaus N; Kafka A; Njirić N; Pećina-Šlaus N
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SSTR-2 as a potential tumour-specific marker for fluorescence-guided meningioma surgery.
    Dijkstra BM; Motekallemi A; den Dunnen WFA; Jeltema JR; van Dam GM; Kruyt FAE; Groen RJM
    Acta Neurochir (Wien); 2018 Aug; 160(8):1539-1546. PubMed ID: 29858948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
    Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
    Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line.
    Deezagi A; Safari N
    Mol Biol Rep; 2020 Nov; 47(11):8727-8737. PubMed ID: 33085048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of tumor stem-like cells from human meningiomas.
    Hueng DY; Sytwu HK; Huang SM; Chang C; Ma HI
    J Neurooncol; 2011 Aug; 104(1):45-53. PubMed ID: 21116836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Landscape of genetic variants in sporadic meningiomas captured with clinical genomics.
    Leclair NK; Shen E; Wu Q; Wolansky L; Becker K; Li L; Bulsara KR
    Acta Neurochir (Wien); 2022 Sep; 164(9):2491-2503. PubMed ID: 35881312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newly established patient-derived organoid model of intracranial meningioma.
    Yamazaki S; Ohka F; Hirano M; Shiraki Y; Motomura K; Tanahashi K; Tsujiuchi T; Motomura A; Aoki K; Shinjo K; Murofushi Y; Kitano Y; Maeda S; Kato A; Shimizu H; Yamaguchi J; Adilijiang A; Wakabayashi T; Saito R; Enomoto A; Kondo Y; Natsume A
    Neuro Oncol; 2021 Nov; 23(11):1936-1948. PubMed ID: 34214169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial 3D-spheroids as a tool to study air pollutant-induced lung pathology.
    Baarsma HA; Van der Veen CHTJ; Lobee D; Mones N; Oosterhout E; Cattani-Cavalieri I; Schmidt M
    SLAS Discov; 2022 Apr; 27(3):185-190. PubMed ID: 35227934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model.
    Huang Z; Yu P; Tang J
    Onco Targets Ther; 2020; 13():5395-5405. PubMed ID: 32606757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.
    Michelhaugh SK; Guastella AR; Varadarajan K; Klinger NV; Parajuli P; Ahmad A; Sethi S; Aboukameel A; Kiousis S; Zitron IM; Ebrahim SA; Polin LA; Sarkar FH; Bollig-Fischer A; Mittal S
    J Transl Med; 2015 Jul; 13():227. PubMed ID: 26174772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering EMT using 3D micro-scaffold to promote hepatic functions for drug hepatotoxicity evaluation.
    Wang J; Chen F; Liu L; Qi C; Wang B; Yan X; Huang C; Hou W; Zhang MQ; Chen Y; Du Y
    Biomaterials; 2016 Jun; 91():11-22. PubMed ID: 26994875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
    Han SJ; Reis G; Kohanbash G; Shrivastav S; Magill ST; Molinaro AM; McDermott MW; Theodosopoulos PV; Aghi MK; Berger MS; Butowski NA; Barani I; Phillips JJ; Perry A; Okada H
    J Neurooncol; 2016 Dec; 130(3):543-552. PubMed ID: 27624915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Landscape of immune cell gene expression is unique in predominantly WHO grade 1 skull base meningiomas when compared to convexity.
    Zador Z; Landry AP; Balas M; Cusimano MD
    Sci Rep; 2020 Jun; 10(1):9065. PubMed ID: 32493984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput microfluidics for evaluating microbubble enhanced delivery of cancer therapeutics in spheroid cultures.
    Bourn MD; Batchelor DVB; Ingram N; McLaughlan JR; Coletta PL; Evans SD; Peyman SA
    J Control Release; 2020 Oct; 326():13-24. PubMed ID: 32562855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathology of meningiomas.
    Solomon DA; Pekmezci M
    Handb Clin Neurol; 2020; 169():87-99. PubMed ID: 32553300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.